Schiff Hardin advised Dawson James Securities, Inc., as placement agents in the transaction
Sonoma Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company, led by James Schutz, Robert Miller and Marc Umscheid develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. In 2017 the company recorded $12.8 Million Sales.
Schiff Hardin advised with a team including Ralph V. De Martino (Picture), Alec Orudjev and Cavas S. Pavri.
Law Firms: Schiff Hardin LLP;
Clients: Dawson James Securities, Inc.;